Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

IAR Systems delivers advanced trace for RISC-V based applications

Enhanced support for the SiFive Insight solution in IAR Embedded Workbench brings leading debug and trace capabilities to the RISC-V communityUppsala, Sweden—June 24, 2020—IAR Systems®, the future-proof supplier of software tools and services for embedded development, has extended the complete development toolchain IAR Embedded Workbench® for RISC-V  with support for trace as implemented by SiFive Insight , the industry’s first combined pre-integrated trace and debug solution for the freely-available, open-

Pharmacolog launches new software for WasteLog®

Pharmacolog is today launching a brand-new software for WasteLog®. The software is designed to provide a quick and effective solution for controlling the returns of narcotic drugs. WasteLog® includes a number of completely unique features and improved workflow.The new WasteLog®, which obtains version number 4.6, is tailor-made for quick and effective control of liquid drugs that remains after surgical procedures. Return control, or Waste Screening, is a fundamental component of programs to prevent narcotic drugs from getting in the wrong hands, so called Drug Diversion Prevention Program.

Steep rise in skin cancer since 1960s

The risk of developing more than one skin melanoma over a ten-year period has seen a ten-fold increase in Sweden since the 1960s, a new study by researchers at Karolinska Institutet and Lund University published in The Journal of the National Cancer Institute reports. The researchers suspect that the increase is due to a change in holiday customs with more active sunbathing and overseas trips to southern climes.“There are many health benefits to being outside, but it would be good if studies like this could encourage people to protect their skin better and find other ways to enjoy their

IRLAB’s mesdopetam featured on cover of top-tier publication JPET

IRLAB announced today that IRLAB's candidate drug mesdopetam (IRL790) is featured on the cover of the July 01, 2020, issue of the highly ranked scientific journal JPET. The cover illustrates how mesdopetam binds to the dopamine D3 receptor. The scientific paper further describes the compounds beneficial system level effects in the brain. Mesdopetam is in development for the treatment of motor and psychiatric complications in Parkinson’s disease."We are proud that IRLAB by means of our systems biology discovery strategy, ISP, has discovered and developed a candidate drug that is now featured

Senzime expands US sales team and signs additional distribution agreements

Press release: Uppsala, June 24, 2020. Senzime AB (publ) today announces that the company has initiated its Sales Ramp Up in the US to establish a direct sales force in key territories and that the company has signed distribution agreements for the Midwest and Northwest territories. “I am proud to say that our strategy is now materializing in the US. Bringing distributors Clinical Technology and Co-Medical on board together with a direct sales team gives us a strong and agile position to transform the US market and introduce the cutting-edge TetraGraph technology to physicians

Registration of capital increase and admission to trading

Company Announcement No. 3-2020Copenhagen, June 24th, 2020As stated in company announcement no. 2, 19 June 2020, the offering of a maximum of 2,755,102 new shares in Shape Robotics A/S was fully subscribed. Yesterday, the capital increase was registered with the Danish Business Authority, and the offering has been completed.Following the capital increase, the share capital of the company is nominally DKK 682,510 divided into 6,825,102 shares with a nominal value of DKK 0.1 each.Nasdaq First North Growth Market Denmark has today confirmed that the company’s shares will be admitted to

BioStock Studio: Scandion Oncology and Alligator Bioscience forge preclinical collaboration

Yesterday, Nils Brünner, CEO of the Danish Scandion Oncology and Per Norlén, CEO of Swedish Alligator Bioscience came together at the BioStock Studio to discuss their newly forged collaboration. The two companies have recently agreed to explore the anti-tumour effect of Alligator’s mitazalimab in combination with Scandion’s SCO-101 as an addition to chemotherapy in resistant preclinical tumour models. The two CEOs expect that SCO-101 will be able to revert chemotherapy resistance and thereby further strengthen the anti-tumour effects of mitazalimab.Watch the video interview with Scandion

Södra announces further expansion of Värö

Södra is planning a new investment for its state-of-the-art pulp mill in Värö which will allow the mill to increase capacity yet further, in steps toward 850,000 tpy.“The investment is part of Södra’s new Group strategy and means that we can continue to follow our chosen path and grow together with our customers. Increasing production will strengthen our competitiveness and our position in the global market as a long-term and secure partner,” said Peter Karlsson, Interim President and CEO at Södra. In 2016, Värö was completely rebuilt to become one of the world’s most modern and largest

82 Ironhand[®] systems delivered to Loxam

As previously communicated, Loxam ordered 82 Ironhand[®] systems to be delivered during the spring. As many other companies Loxam was affected by the Covid-19 pandemic and closed several of their rental sites. As Loxam reopened their sites, we completed our deliveries of Ironhand[®] systems. Before the pandemic approximately 22 Ironhand[®] units, including gloves and carry solutions were shipped to a couple of Loxam locations. As Loxam started to open their rental sites again after the pandemic, we resumed our deliveries. During the past weeks we have completed the delivery of the 82

Ahlstrom-Munksjö’s sustainability work awarded with fourth consecutive EcoVadis Gold rating

AHLSTROM-MUNKSJÖ OYJ PRESS RELEASE JUNE 24, 2020 at 10:00 a.m. EEST Ahlstrom-Munksjö has been awarded with EcoVadis Gold rating for the company’s sustainability management and performance for the fourth consecutive year. Compared with the results from the previous year, progress was especially made in sustainable procurement. EcoVadis is a globally recognized business sustainability rating provider. The Corporate Social Responsibility assessment criteria include four themes; environment, labor practices, sustainable procurement and fair business practices. The EcoVadis method is based

Further update on the impact of the Corona virus on the Björn Borg Group

As previously communicated, the outbreak of the Corona virus has negative impact on the Björn Borg Group’s business. Björn Borg continues to take measures to minimize the negative effects of the outbreak and plans to reduce the number of employees with approximately 19. persons at the headquarters in Stockholm during 2020, after negotiations with relevant unions have been concluded. The estimated annual savings from the planned staff reduction is approximately SEK 20 million.The company continues to see negative effects of the outbreak in the retail market with significantly reduced

NENT Group and Elisa to combine streaming services in Finland

· Innovative agreement to combine Viaplay’s ‘Films & Series’ package with Elisa Viihde Aitio’s content into a standalone streaming service in Q4 2020 · Current and new Viaplay and Elisa Viihde Aitio customers in Finland will have access to both services from 30 June · Combined service will be called Elisa Viihde Viaplay and will accelerate NENT Group’s streaming ambitions in Finland Nordic Entertainment Group (NENT Group), the Nordic region’s leading streaming company, and Elisa, Finland’s market-leading telecoms operator, will combine their streaming services in Finland in Q4 2020.

Peab builds apartments in Sarpsborg

Peab has been commissioned to build 50 apartments in Sarpsborg, southeast of Oslo. The customer is HABO and Jack Valleraune and the contract is worth NOK 103.5 million.The project entails building five buildings containing 50 apartments for a total of 5,000 m2. The apartments will vary in size from 76 to 125 m2. “This is a fantastic project that permits us to build new homes in Sarpsborg. The apartment buildings will be built with a concrete construction and a lot of wood in the facade, which will make them fit in well with the environment around Glomma River,” says Trond Bergsland,

NextCell Pharma AB’s rights issue heavily oversubscribed

The Board of Directors of NextCell Pharma AB ("NextCell" or the “Company”) announces today the outcome in the Company’s new issue of shares with preferential rights for existing shareholders (the “Rights Issue”). The demand was high and the Rights Issue was oversubscribed. Thus, no guarantees have been utilized. Through the Rights Issue, the Company receives approximately SEK 25.1 million before transaction costs.· 4,111,192 shares were subscribed using subscription rights · In addition, applications for subscription without using subscription rights corresponding to 11,750,102 shares

K-Fastigheter buys building right to build 60 rental apartments in Gävle

K-Fast Holding AB and BoKlok have signed an agreement on the development of a building right in Gävle, and are planning to construct 60 rental apartments with a lettable area of 3,876 square metres.The strategic partnership between K-Fast Holding AB (“K-Fastigheter”) and BoKlok, a company jointly owned by Skanska and IKEA, was initiated in April 2020 with the aim of developing building rights and affordable housing. The goal of the collaboration is to jointly build up to a thousand apartments over the next three years. In Gävle, K-Fastigheter acquires part of the property Gävle Sätra 108:

Dicot’s rights issue is heavily oversubscribed

Press release: Uppsala, June 24, 2020. The rights issue of SEK 21.8 million which was disclosed on April 23, 2020 and resolved by the annual general meeting on May 26, 2020 (the ”Rights Issue”)  in Dicot AB (publ) (”Dicot” or the "Company") has been heavily oversubscribed. The Rights Issue was subscribed to 326 percent. Through the Rights Issue, the Company obtains approximately SEK 21.8 million before issue costs.SubscriptionThe subscription period ended on June 18, 2020. The Rights Issue was subscribed with 326 percent, of which approximately 97 percent was subscribed with unit rights

Notice of extraordinary general meeting of CELLINK AB (publ)

The shareholders of CELLINK AB (publ), Reg. No. 559050-5052 (“Cellink”), with registered office in Gothenburg, are hereby invited to the extraordinary general meeting on Thursday, 16 July 2020. Cellink is mindful of the health and well-being of its shareholders and employees. It´s important for Cellink to take a social responsibility and contribute to reduce the risk of transmission of the Covid-19. Due to the extraordinary situation the extraordinary general meeting will be carried out through advance voting (postal voting) pursuant to temporary legislation. Thus, it will not be

Ziccum AB (publ) completes directed share issue of SEK 38.8 million to accelerate development of temperature-stable vaccines

The Board of Directors of Ziccum AB ("Ziccum" or "the Company") today resolved and successfully implemented a private placement of a total of 2,216,815 shares to a limited number of qualified private investors, supported by authorization from Annual General Meeting on June 16. Ziccum is allocated SEK 38.8 million before issue costs. The capital ensures the Company's long-term financing and enables accelerated development of production of temperature-stable vaccines.The subscription price in the directed share issue has been determined through a so-called accelerated bookbuilding process and

Quarterly Report III 19/20

September 2019 – May 2020, Diamyd Medical AB (publ), Fiscal year 2019/2020Developing therapies for type 1 diabetesDiamyd Medical’s B-share is traded on Nasdaq First North Growth Market under the ticker DMYD B.Further information is available on https://www.diamyd.com Figures in parentheses relate to the corresponding period previous financial year. September 1, 2019 – May 31, 2020 · Net result: MSEK 23.2 (-26.8), whereof third quarter MSEK -7.2 (-7.9). The increase compared to previous year is a one-off effect due to a payment of corresponding MSEK 48.0 from the previous

Statement by the board of directors of NetEnt in relation to the public offer from Evolution Gaming

The board of directors unanimously recommends the shareholders of NetEnt to accept the offer from Evolution Gaming. This statement is made by the board of directors[1] of NetEnt AB (publ) (“NetEnt” or the “Company”) pursuant to Rule II.19 of the Nasdaq Stockholm Takeover Rules (the “Takeover Rules”). The Offer On 24 June 2020, Evolution Gaming Group AB (publ) (“Evolution Gaming”) announced an offer of 0.1306 Evolution Gaming shares for each share in NetEnt (the “Offer”). The Offer values each share in NetEnt to SEK 79.93 and all shares in NetEnt to approximately SEK 19.6 billion

NattoPharma enters partnership with KD Pharma

NattoPharma and KD Nutra have entered into a partnership agreement to promote KD-PüR® high concentrate Omega-3s and MenaQ7® PharmaPure MK-7 combinationOslo, Norway (24 june 2020) — NattoPharma has entered into a partnership agreement with KD Nutra – a KD Pharma Group company – to create an innovative cardiovascular-support ingredient that combines KD Nutra’s KD-PüR® high concentrate omega-3s with NattoPharma’s category leading nature-identical Vitamin K2, MenaQ7® PharmaPure MK-7. The exclusive partnership for KD-Pür® EPA and DHA ≥ 70% Concentrates and MenaQ7® K2 is available as part of

Invitation to conference call by Evolution Gaming in connection with the recommended public offer to the shareholders of NetEnt

Evolution Gaming Group AB (publ) has today announced a recommended public offer to the shareholders of NetEnt AB (publ). In connection with this, Evolution invites investors, analysts and media to a conference call and webcast on 24 June 2020 at 09:00 CEST.To follow the call via webcast, visit:https://tv.streamfabriken.com/press-conference-2020-06-24 To participate in the call, please dial:SE: +46 8 5055 8373UK: +44 3333 00 9272US: +1 833 249 8405 Please dial-in ten minutes prior to the start of the call to avoid delay. For more information, please contact:Jacob Kaplan,

ABS Grants AIP to Dual Deadweight Bulker

ABS Supporting Standship JDP’s Innovations in Vessel Design(GENEVA) ABS granted Approval in Principle (AIP) to a dual deadweight neo-panamax bulk carrier design from the StandShip Joint Development Partnership (JDP).Available in 86,000 and 95,000 DWT designs, the bulk carrier is intended to be ready to order ‘off the shelf’ for charterers and operators looking for flexibility. The 229m design includes a 38m beam, almost four million cubic feet of hold capacity and a draft of either 13.5m or 14.55m depending on the deadweight option selected.“ABS has a proud record of supporting

Coor extends IFM agreement with Telia Company in Norway and Sweden

Coor has worked with Telia Company in the Nordics for over ten years, and is now extending the contract in a Vested Outsourcing Agreement over five years with an annual value of just over SEK 100 M.The Vested Outsourcing Agreement encompasses a large number of workplace services including cleaning, reception and conference services. The assignment relates to delivery to some 50 facilities in Sweden and Norway. The aim of the agreement is to develop Coor’s FM delivery in line with Telia Company’s key business goals, such as generating cost savings and increasing user satisfaction, with a

There are no items matching the current filter
There are no more items matching the current filter
Back to top